China's Golden Meditech, Fenwal Of U.S. Form Joint Blood Device Venture
This article was originally published in PharmAsia News
Executive Summary
The Chinese healthcare company Golden Meditech has formed a joint venture with U.S.-based Fenwal, a medical-device maker. The venture, to be located in Beijing, plans to produce blood-collection and tranfusion products for Chinese use. Both Fenwal and Golden Meditech make healthcare products. Fenwal is known for its Amicus cell-separation system to collect platelets and Golden Meditech for its 3000H Plasma Exchange system to remove toxins from blood. The joint venture is expected to be completed early next year with Fenwal owning 51 percent. (Click here for more